Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients

Transcriptional activation by estrogen receptor (ER) is a key step to breast oncogenesis. Given previous findings that ADA3 is a critical component of HAT complexes that regulate ER function and evidence that overexpression of other ER coactivators such as SRC-3 is associated with clinical outcomes...

詳細記述

保存先:
書誌詳細
主要な著者: Mirza, Sameer, Rakha, Emad A., Alshareeda, Alaa, Mohibi, Shakur, Zhao, Xiangshan, Katafiasz, Bryan J., Wang, Jun, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Ellis, Ian O., Green, Andrew R., Band, Hamid, Band, Vimla
フォーマット: Artigo
言語:Inglês
出版事項: Springer US 2013
主題:
Preclinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3552361/
https://ncbi.nlm.nih.gov/pubmed/23288344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2363-3
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料